Literature DB >> 19419311

CXCL12/CXCR4 axis in tissue targeting and bone destruction in cancer and multiple myeloma.

Li Laine Ooi1, Colin R Dunstan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19419311     DOI： 10.1359/jbmr.090503

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  6 in total

Review 1.  The functional role of reactive stroma in benign prostatic hyperplasia.

Authors:  Isaiah G Schauer; David R Rowley
Journal:  Differentiation       Date:  2011-06-12       Impact factor: 3.880

Review 2.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

3.  Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.

Authors:  Ken Tawara; Julia T Oxford; Cheryl L Jorcyk
Journal:  Cancer Manag Res       Date:  2011-05-18       Impact factor: 3.989

4.  The Analysis of the Relationship between Multiple Myeloma Cells and Their Microenvironment.

Authors:  Artur Jurczyszyn; Jacek Czepiel; Joanna Gdula-Argasińska; William Perucki; Aleksander B Skotnicki; Marcin Majka
Journal:  J Cancer       Date:  2015-01-05       Impact factor: 4.207

5.  Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse.

Authors:  Jiyeon Ryu; Youngil Koh; Hyejoo Park; Dae Yoon Kim; Dong Chan Kim; Ja Min Byun; Hyun Jung Lee; Sung-Soo Yoon
Journal:  Mol Cells       Date:  2016-12-21       Impact factor: 5.034

6.  CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.

Authors:  Wen Shen; Xue-Ming Hu; Yan-Nan Liu; Yuan Han; Li-Ping Chen; Chen-Chen Wang; Chao Song
Journal:  J Neuroinflammation       Date:  2014-04-16       Impact factor: 8.322
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.